Keyrus Life Science is a Connected Contract Research Organization (C2RO), operating internationally for almost 25 years as part of the Keyrus group, renowned for its expertise in data and digital solutions. Through the integration of scientific and industry know-how, a comprehensive understanding of life data sciences, and the adoption of cutting-edge digital technologies, Keyrus Life Science optimizes the efficiency of clinical trials and RWE projects. This enhances their agility, reliability, resilience, and execution speed. The company caters to various life science industries including Biotechnology, Life Sciences, and Pharmaceutical, providing a wide range of services under three delivery models: Project, Service Platforms (FSP), and Consulting. Keyrus Life Science supports pharmaceutical, biotech, and medtech companies in their clinical R&D across diverse therapeutic areas. Their services encompass the entire spectrum of clinical development, including strategy framing, operationalization, implementation of real-world evidence (RWE) and late-phase projects, life data science enablement, and digital innovation. The company excels in orchestrating data and technologies to enhance patient outcomes, facilitate the development of precision therapeutic solutions, and promote translational clinical research and predictive medicine. For more details on their expertise and services, visit https://keyruslifescience.com.
There is no investment information
No recent news or press coverage available for Keyrus Life Science.